Table 2.
In vitro activity of polymyxin B and miconazole against Pseudomonas aeruginosa strains
| QC strain | Germany | France | Italy | Total | |
|---|---|---|---|---|---|
| MIC for polymyxin B (μg/mL) | |||||
| n | 8 | 8 | 8 | 24 | |
| Mode | 0.27 | 0.27 | 0.54 | 0.54 | 0.54 |
| Median | 0.54 | 0.54 | 0.54 | 0.54 | |
| IQR | 1.07–0.27 | 0.54–0.27 | 1.07–0.54 | 1.07–0.27 | |
| Minimum | 0.27 | 0.27 | 0.27 | 0.27 | |
| Maximum | >275 | 1.07 | 1.07 | >275 | |
| FICI for polymyxin B and miconazole | |||||
| n | 6 | 8 | 8 | 22 | |
| Mode | 0.50 | 0.50 | 0.25 | 0.50 | 0.50 |
| Median | 0.50 | 0.25 | 0.50 | 0.50 | |
| IQR | 0.50–0.50 | 0.50–0.25 | 0.63–0.44 | 0.50–0.25 | |
| Minimum | 0.13 | 0.13 | 0.25 | 0.13 | |
| Maximum | 0.50 | 1.00 | 1.00 | 1.00 | |
| P-values | |||||
| pc | 0.200 | ||||
| p<1.0 | 4.7 × 10−5 | ||||
| p<0.5 | 0.348 | ||||
Abbreviations are as for Table 1.